Clinical Trial Update: Pharmacokinetic Study of Forodesine in Children With Relapsed or Refractory T-cell or B-cell Precursor Acute Lymphoblastic Leukaemia or T-cell Non- Hodgkin's Lymphoma. [Phase 1, Phase 2]

View source ↗

Summary

Terminated Phase 1/2 pharmacokinetic study of forodesine in children with relapsed or refractory T-cell or B-cell precursor acute lymphoblastic leukemia and T-c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Precursor Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia
• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• Forodesine (forodesine)

Snippet

Sponsor: Mundipharma Research Limited | Conditions: Relapsed or Refractory T-cell Acute Lymphoblastic Leukaemia, B-cell Precursor Acute Lymphoblastic Leukaemia | Phase 1, Phase 2 | Status: TERMINATED